EdgarLookup

Ultragenyx Pharmaceutical Inc.

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to Ultragenyx Pharmaceutical Inc.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

ARCT
Company Title Type Shares Price Value Date
ARCT Sale 725,000 $55.44 $40,194,000 Aug 11, 2021
ARCT Sale 442,255 $105.54 $46,675,593 Dec 9, 2020
ARCT Option Exercise 600,000 $16.00 $9,600,000 May 20, 2020